Hiroyuki Ida

TL;DR: It is suggested that vitamin D(3) supplementation during the winter may reduce the incidence of influenza A, especially in specific subgroups of schoolchildren.

TL;DR: All patients with type 1 Gaucher disease should undergo comprehensive regular assessment, the frequency of which depends on treatment status and whether therapeutic goals have been achieved, and reassessment should be performed whenever enzyme therapy dose is altered, or in case of significant clinical complication.

TL;DR: Idursulfase treatment appears to be safe and effective in adult Japanese patients with attenuated MPS II and advanced disease, comparable to those of prior studies that enrolled predominantly pediatric, Caucasian, and less ill patients.

TL;DR: It is suggested that NOV works as a chemical chaperone to accelerate transport and maturation of F213I mutant β-Glu and may suggest a therapeutic value of this compound for GD.

TL;DR: The diversity of GBA gene mutations from patients with Gaucher disease represented in the ICGG Gaucher Registry database and in the literature provides the basis for initial genotype/phenotype correlations, the outcomes of which are summarized here.